secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2023-12-15T23:59:59+00:00
Accession:  0000950170-23-070509
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics CFO Jason Amello resigns; Charles Schoch appointed interim CFO
--------------------------------------------------------------------------------

- Jason Amello resigned as CFO, principal financial and accounting officer, effective January 12, 2024, to pursue another opportunity.
- Resignation not due to any disagreement with auditors or company on operations, policies, or financial disclosures.
- Charles Schoch, VP of Finance and Corporate Controller, will serve as Interim CFO while a permanent replacement is sought.
- Amello will remain as an advisor to support transition of responsibilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000095017023070509/0000950170-23-070509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000095017023070509/cadl-20231211.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-070509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer